All Stories

  1. Conjugation of Penicillin-G with Silver(I) Ions Expands Its Antimicrobial Activity against Gram Negative Bacteria
  2. Fluorescence of copper(I) and mixed valence copper(I/II) complexes with dipicolinic acid and their catalytic activity on catechol oxidation
  3. Ciprofloxacin conjugated to diphenyltin(iv): a novel formulation with enhanced antimicrobial activity
  4. Antiproliferative activity and apoptosis induction, of organo-antimony(III)–copper(I) conjugates, against human breast cancer cells
  5. An Efficient Disinfectant, Composite Material {SLS@[Zn3(CitH)2]} as Ingredient for Development of Sterilized and Non Infectious Contact Lens
  6. Structural architectures and biological properties of main group bismuth(III) iodide complexes with heterocyclic thioamides
  7. Synthesis, characterization and biological evaluation of novel antimony(III) iodide complexes with tetramethylthiourea and N-ethylthiourea
  8. Anti-proliferative and antitumor activity of organotin(IV) compounds. An overview of the last decade and future perspectives
  9. Diclofenac conjugates with biocides through silver(I) ions (CoMeD's); Development of a reliable model for the prediction of anti-proliferation of NSAID's-silver formulations.
  10. Non steroidal anti-inflammatory drug (NSAIDs) in breast cancer chemotherapy; antimony(V) salicylate a DNA binder
  11. The periodic table of urea derivative: small molecules of zinc(II) and nickel(II) of diverse antimicrobial and antiproliferative applications
  12. A water-soluble silver(I) formulation as an effective disinfectant of contact lenses cases
  13. Preface to “A Commemorative Issue in Honour of Professor Nick Hadjiliadis: Metal Complex Interactions with Nucleic Acids and/or DNA”
  14. Bismuth(III) bromide-thioamide complexes: synthesis, characterization and cytotoxic properties
  15. Poly Organotin Acetates against DNA with Possible Implementation on Human Breast Cancer
  16. Silver ciprofloxacin (CIPAG): a successful combination of chemically modified antibiotic in inorganic–organic hybrid
  17. Silver complex of salicylic acid and its hydrogel-cream in wound healing chemotherapy
  18. Innovative material containing the natural product curcumin, with enhanced antimicrobial properties for active packaging
  19. Cytotoxic effect, antitumour activity and toxicity of organotin derivatives with ortho- or para-hydroxy-benzoic acids
  20. Chloro(triphenylphosphine)gold(I) a forefront reagent in gold chemistry as apoptotic agent for cancer cells
  21. Synthesis, characterization and cytotoxic properties of bismuth(III) chloride complexes with heterocyclic thioamides
  22. New metalo-therapeutics of NSAIDs against human breast cancer cells
  23. Synthesis, characterization and biological activities of copper(II) complex of 2-Benzimidazolyl-urea and the nitrate salt of 2-Benzimidazolyl-urea
  24. Molecular Docking and Structure Activity Relationship Studies of NSAIDs. What do they Reveal about IC50?
  25. Synthesis characterization and biological activity of mixed ligand silver(I) complex of 2-benzimidazolylurea and triphenylphosphine
  26. QSAR studies on antimony(III) halide complexes with N-substituted thiourea derivatives
  27. Silver(I) complexes of methyl xanthate against human adenocarcinoma breast cancer cells
  28. N-(4-Hydroxyphenyl)acetamide against diiodine towards polyiodide dianion
  29. Platinum(II)-thiosemicarbazone drugs override the cell resistance due to glutathione; assessment of their activity against human adenocarcinoma cells
  30. Structural, photolysis and biological studies of novel mixed metal Cu(I)-Sb(III) mixed ligand complexes
  31. Nimesulide Silver Metallodrugs, Containing the Mitochondriotropic, Triaryl Derivatives of Pnictogen; Anticancer Activity against Human Breast Cancer Cells
  32. New antibacterial, non-genotoxic materials, derived from the functionalization of the anti-thyroid drug methimazole with silver ions
  33. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Metal Complexes and Their Effect at the Cellular Level
  34. Addition of tetraethylthiuram disulfide to antimony(III) iodide; synthesis, characterization and biological activity
  35. Novel bismuth compounds: synthesis, characterization and biological activity against human adenocarcinoma cells
  36. New antimony(III) halide complexes with dithiocarbamate ligands derived from thiuram degradation: The effect of the molecule's close contacts on in vitro cytotoxic activity
  37. Recent advances on antimony(III/V) compounds with potential activity against tumor cells
  38. Novel mixed metal Ag(I)-Sb(III)-metallotherapeutics of the NSAIDs, aspirin and salicylic acid: Enhancement of their solubility and bioactivity by using the surfactant CTAB
  39. Rational Drug Design Paradigms: The Odyssey for Designing Better Drugs
  40. Mono-nuclear cis-Pd(II) chloride complex of the thio-nucleotide analogue 5-methyl-thiouracil and its biological activity
  41. Silver(I) compounds of the anti-inflammatory agents salicylic acid and p-hydroxyl-benzoic acid which modulate cell function
  42. Stability and binding effects of silver(I) complexes at lipoxygenase-1
  43. Assessment of organotins against the linoleic acid, glutathione and CT-DNA
  44. Antimony(III) halide compounds of thioureas: Structures and biological activity
  45. Mono- and Binuclear Copper(I) Complexes of Thionucleotide Analogues and Their Catalytic Activity on the Synthesis of Dihydrofurans
  46. A novel silver iodide metalo-drug: Experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione
  47. Synthesis, structural characterization and cytostatic properties of N,N-dicyclohexyldithiooxamide complexes of antimony(III) halides (SbX3, X: Br or I)
  48. Synthesis, characterization, and binding properties towards CT-DNA and lipoxygenase of mixed-ligand silver(I) complexes with 2-mercaptothiazole and its derivatives and triphenylphosphine
  49. Fundamental chemistry of iodine. The reaction of di-iodine towards thiourea and its methyl-derivative: formation of aminothiazoles and aminothiadiazoles through dicationic disulfides
  50. Novel metallo-therapeutics of the NSAID naproxen. Interaction with intracellular components that leads the cells to apoptosis
  51. Synthesis, antiradical activity and in vitro cytotoxicity of novel organotin complexes based on 2,6-di-tert-butyl-4-mercaptophenol
  52. Synthesis, characterization and biological activity of antimony(III) or bismuth(III) chloride complexes with dithiocarbamate ligands derived from thiuram degradation
  53. Synthesis, structural characterization and cytotoxicity of the antimony(III) chloride complex with N,N-dicyclohexyldithiooxamide
  54. Anti-proliferative and anti-tumor activity of silver(i) compounds
  55. The impact of the anion size on the crystal packing in 2-mercaptopyrimidine halides; isostructurality and polymorphism
  56. Comparative Binding Effects of Aspirin and Anti-Inflammatory Cu Complex in the Active Site of LOX-1
  57. Synthesis and Structural Characterization of New Cu(I) Complexes with the Antithyroid Drug 6-n-Propyl-thiouracil. Study of the Cu(I)-Catalyzed Intermolecular Cycloaddition of Iodonium Ylides toward Benzo[b]furans with Pharmaceutical Imple...
  58. Photo-activated metallotherapeutics: copper(I) or silver(I) mixed ligand complexes with 2-mercaptopyrimidine and triphenylphosphine
  59. Synthesis, characterization and biological studies of new antimony(III) halide complexes with ω-thiocaprolactam
  60. Copper(I)/(II) or silver(I) ions towards 2-mercaptopyrimidine: An exploration of a chemical variability with possible biological implication
  61. Structural characterization of polymeric potassium salts with 2-thiobarbituric acid: influence of organotin(IV) chlorides on potassium cation solvation
  62. Synthesis, structural characterization and in vitro inhibitory studies against human breast cancer of the bis-(2,6-di-tert-butylphenol)tin(iv) dichloride and its complexes
  63. Stabilization of poly-iodides: structural influences of the cationic disulfides of 2-mercapto-3,4,5,6-tetrahydro-pyrimidine and 2-mercatpo-pyrimidine
  64. Structural and In Vitro Biological Studies of Organotin(IV) Precursors; Selective Inhibitory Activity Against Human Breast Cancer Cells, Positive to Estrogen Receptors
  65. Reactivity of di‐iodine toward thiol: Desulfuration reaction of 5‐nitro‐2‐mercapto‐benzimidazole upon reaction with di‐iodine
  66. Mixed ligand–silver(i) complexes with anti-inflammatory agents which can bind to lipoxygenase and calf-thymus DNA, modulating their function and inducing apoptosis
  67. Study on single crystal structure of the antimony(III) bromide complex with 3-methyl-2-mercaptobenzothiazole and biological activity of some antimony(III) bromide complexes with thioamides
  68. Interaction of antimony(III) chloride with thiourea, 2-mercapto-5-methyl-benzimidazole, 3-methyl-2-mercaptobenzothiazole, 2-mercaptopyrimidine, and 2-mercaptopyridine
  69. Bromidotris(triphenylphosphane)silver acetonitrile monosolvate monohydrate
  70. Synthesis, structural characterization and biological studies of novel mixed ligand Ag(I) complexes with triphenylphosphine and aspirin or salicylic acid
  71. Synthesis, structural characterization and biological studies of the triphenyltin(IV) complex with 2-thiobarbituric acid
  72. Uncertainty Analysis of Drug Concentration in Pharmaceutical Mixtures
  73. Anticancer and cytotoxic effects of a triorganotin compound with 2-mercapto-nicotinic acid in malignant cell lines and tumor bearing Wistar rats
  74. Structural characterization of the {3[ΗBPMTU]+ · 3[X]− · nH2O} salts (BPMTU = 1,3-bis(3-pyridylmethyl)-2-thiourea and X = Cl, Br, I). A polychlorine network based on O ··· Cl−and OH ··· Cl−i...
  75. Inhibition of peroxidase-catalyzed iodination by thioamides: experimental and theoretical study of the antithyroid activity of thioamides
  76. Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides
  77. Structural, photolysis and biological studies of the bis(μ2-chloro)-tris(triphenylphosphine)-di-copper(I) and chloro-tris(triphenylphosphine)-copper(I) complexes. Study of copper(I)–copper(I) interactions
  78. Structural Properties, Cytotoxicity, and Anti‐Inflammatory Activity of Silver(I) Complexes with tris(p‐tolyl)Phosphine and 5‐Chloro‐2‐Mercaptobenzothiazole
  79. Structural Motifs and Biological Studies of New Antimony(III) Iodide Complexes with Thiones
  80. Palladium coordination compounds as anti-viral, anti-fungal, anti-microbial and anti-tumor agents
  81. New Antimony(III) Bromide Complexes with Thioamides: Synthesis, Characterization, and Cytostatic Properties
  82. Tetrameric 1:1 and monomeric 1:3 complexes of silver(I) halides with tri(p-tolyl)-phosphine: A structural and biological study
  83. Synthesis, structural characterization and in vitro cytotoxicity of new Au(III) and Au(I) complexes with thioamides
  84. Synthesis, Characterization, and Biological Studies of Organotin(IV) Derivatives with o‐ or p‐hydroxybenzoic Acids
  85. Antiproliferative and anti-tumor activity of organotin compounds
  86. Anticancer Therapeutics
  87. Structural and biological studies of organotin(IV) derivatives with 2-mercapto-benzoic acid and 2-mercapto-4-methyl-pyrimidine
  88. ChemInform Abstract: Synthesis, Structural Characterization and Biological Study of New Organotin(IV), Silver(I) and Antimony(III) Complexes with Thioamides
  89. Synthesis, structural characterization and biological study of new organotin(IV), silver(I) and antimony(III) complexes with thioamides
  90. Biological studies of new organotin(IV) complexes of thioamide ligands
  91. ChemInform Abstract: Interaction of Thioamides, Selenoamides, and Amides with Diiodine
  92. Structural motifs of diiodine complexes with amides and thioamides
  93. Crystal Structure and Antitumor Activity of the Novel Zwitterionic Complex of tri‐n‐Butyltin(IV) with 2‐Thiobarbituric Acid
  94. Synthesis, Structural Characterization, and Biological Studies of New Antimony(III) Complexes with Thiones. The Influence of the Solvent on the Geometry of the Complexes
  95. Biological studies of organotin(IV) complexes with 2-mercaptopyrimidine
  96. A New Silver(I) Aggregate Having an Octagonal Ag4S4 Core Where μ3‐S Bonding Interactions Lead to a Nanotube Assembly that Exhibits Quasiaromaticity
  97. Synthesis, Structural Characterization, and Biological Studies of Six- and Five-Coordinate Organotin(IV) Complexes with the Thioamides 2-Mercaptobenzothiazole, 5-Chloro-2-mercaptobenzothiazole, and 2-Mercaptobenzoxazole
  98. Synthesis and Structures of Se Analogues of the Antithyroid Drug 6‐n‐Propyl‐2‐thiouracil and Its Alkyl Derivatives: Formation of Dimeric Se–Se Compounds and Deselenation Reactions of Charge‐Transfer Adducts of Diiodine
  99. Structural characterization of selenium and selenium-diiodine analogues of the antithyroid drug 6-n-propyl-2-thiouracil and its alkyl derivatives
  100. Novel organotin(IV) compounds derived from bis(organostannyl)methanes: Synthesis and crystal structures of bis[diphenyl(pyridin-2-onato)stannyl]methane and bis[bromophenyl(pyrimidine-2-thionato)stannyl]methane·C7H8
  101. Synthesis and characterization of a new chloro-di-phenyltin(IV) complex with 2-mercapto-nicotinic acid: Study of its influence upon the catalytic oxidation of linoleic acid to hydroperoxylinoleic acid by the enzyme lipoxygenase
  102. Interaction of Thioamides, Selenoamides, and Amides with Diiodine
  103. Pressure‐Tuning Raman Spectra of Diiodine Thioamide Compounds: Models for Antithyroid Drug Activity
  104. Synthesis, structural characterization and study of {[K(H2mna)2]+· [K(μ-OH)2]−· 4H2O} (H2mna = 2-mercapto-nicotinic acid). A supramolecular architecture of inorganic/metal-organic hybrid self-assembled by strong hydrogen bonds and π–π interactions
  105. Synthesis, Structural Characterization, and Computational Studies of Novel Diiodine Adducts with the Heterocyclic Thioamides N-Methylbenzothiazole-2-thione and Benzimidazole-2-thione:  Implications with the Mechanism of Action of Antithyroid Drugs
  106. Synthesis and characterization of new water stable antimony(III) complex with pyrimidine-2-thione and in vitro biological study
  107. An Exploration of the Structural and Bonding Variability in Mixed‐Ligand Benzimidazole‐2‐thione(bromo)(triarylphosphane)dicopper(I) Complexes with Diamond‐Shaped Cu2(μ‐X)2 Core Structures
  108. 46 Pd The Use of Palladium Complexes in Medicine
  109. Synthesis, X-ray characterization and study of new ionic complexes of 2-pyridone, obtained by oxidation with I2
  110. Effects of non-steroid anti-inflammatory drugs in membrane bilayers
  111. Synthesis, X‐ray Characterisation and Studies of the New Ionic Complex [Bis(pyridin‐2‐yl) disulfide] Triiodide, Obtained by Oxidation of 2‐Mercaptopyridine with I2 − Implications in the Mechanism of Action of Antithyroid Drugs
  112. Crystallographic report: Diphenylbis(Hpiroxicam)tin(IV), [Ph2Sn(Hpir)2]
  113. Synthesis, Characterization and in Vitro Study of the Cytostatic and Antiviral Activity of New Polymeric Silver(I) Complexes with Ribbon Structures Derived from the Conjugated Heterocyclic Thioamide 2-Mercapto-3,4,5,6-tetra- hydropyrimidine
  114. Organotin(IV) Derivatives of L‐Cysteine and their in vitro Anti‐Tumor Properties
  115. Synthesis, structural characterization and in vitro cytotoxicity of organotin(IV) derivatives of heterocyclic thioamides, 2-mercaptobenzothiazole, 5-chloro-2-mercaptobenzothiazole, 3-methyl-2-mercaptobenzothiazole and 2-mercaptonicotinic acid
  116. Synthesis and Characterization of (PTU)I2 (PTU = 6‐n‐propyl‐2‐thiouracil) and (CMBZT)I2 (CMBZT = 5‐chloro‐2‐mercaptobenzothiazole) and Possible Implications for the Mechanism of Action of Anti‐Thyroid Drugs
  117. Synthesis, study and structural characterization of a new water soluble hexanuclear silver(I) cluster with the 2-mercapto-nicotinic acid with possible antiviral activity
  118. Communication: Synthesis of a Novel Triphenyltin(IV) Derivative of 2‐Mercaptonicotinic Acid with Potent Cytotoxicity in vitro
  119. High-pressure Fourier transform micro-Raman spectroscopic investigation of diiodine-heterocyclic thioamide adducts
  120. Copper(I) Halide Complexes with Triphenylphosphane and Heterocyclic Thione Ligands: The Crystal Structures of [Bis(Triphenylphosphane)(Benzimidazole-2-Thione)Copper(I) Iodide], [Bis(Triphenylphosphane)(Benzothiazole-2-Thione)Copper(I) Iodide], and Bis[...
  121. Synthesis, Spectroscopic and Structural Characterization of Novel Diiodine Adducts with the Heterocyclic Thioamides, Thiazolidine-2-thione (tzdtH), Benzothiazole-2-thione (bztzdtH) and Benzimidazole-2-thione (bzimtH)
  122. Solvent-controlled assembling by hydrogen bridges and halogen-halogen interactions of novel organotin oxo clustersElectronic supplementary information (ESI) available: Synthesis and analytical data for PhI2SnCH2SnI2Ph. See http://www.rsc.org/suppdata/c...
  123. Synthesis, characterisation and study of mercury(II) bromide complexes with triphenylphosphine and heterocyclic thiones. The crystal structures of [bis(triphenylphosphine) dibromo mercury(II)] and [dibromo (pyrimidine-2-thionato) (triphenylphosphine) m...
  124. Silver(I) complexes with heterocyclic thiones and tertiary phosphines as ligands. Part 4. Dinuclear complexes of silver(I) bromide: the crystal structure of bis[bromo-(pyrimidine-2-thione)(triphenylphosphine)silver(I)]
  125. Synthesis, characterisation and study of mercury(II) chloride complexes with triphenylphosphine and heterocyclic thiones. The crystal structures of [(benzothiazole-2-thionato)(benzothiazole-2-thione)(bis-triphenylphosphine) chloro mercury(II)] and [(μ2...
  126. Organotin adducts with pyrimidinethione: crystal structure of dimethyldi(pyrimidine-2-thiolato)tin(IV) and diphenyldi(pyrimidine-2-thiolato)tin(IV)
  127. Synthesis, spectroscopic and computational studies plus crystal structure of [(bis-benzo-1,3-thiazolidine-2-thione) (bis-triphenylphoshine)copper(I)][chloro(benzothiazolidine-2-thione)(bis-triphenylphoshine)copper(I)]
  128. Palladium(II) and platinum(II) complexes of pyridine-2-carbaldehyde thiosemicarbazone with potential biological activity. Synthesis, structure and spectral properties. Extended network via hydrogen bond linkages of [Pd(PyTsc)Cl]
  129. Synthesis and characterisation of the first organotin complex of piroxicam. An extended network system via non-hydrogen, hydrogen bonding linkages and C–H  · · ·  π contacts
  130. Anti-inflammatory properties of diclofenac transition metalloelement complexes
  131. Synthesis and characterization of copper(I) complexes with triphenylphosphine and heterocyclic thione ligands: the crystal structure of (thiazolidine-2-thione)(bis-triphenylphosphine) copper(I) chloride
  132. Metal ion–drug interactions. Preparation and properties of manganese (II), cobalt (II) and nickel (II) complexes of diclofenac with potentially interesting anti-inflammatory activity: Behavior in the oxidation of 3,5-di-tert-butyl-o-catechol
  133. Electrochemical reduction of dinuclear copper(I) mixed ligand complexes with tri-m-tolylphosphine and heterocyclic thiones
  134. Preparation and spectral studies of dinuclear mixed-ligand copper(I) complexes. The crystal structure of bis[μ-s(pyridine-2-thione)(tmtp) copper(I) bromide]
  135. ChemInform Abstract: Low Valent Coinage Metal Coordination Compounds With Tertiary Phosphines and Thiones
  136. MIXED LIGAND COORDINATION COMPOUNDS OF COPPER(I) WITH HETEROCYCLIC THIONES AND TERTIARY PHOSPHINES. THE CRYSTAL STRUCTURE OF BIS (QUINOLINE-2-THIONE) BISTRIPHENYLPHOSPHINO COPPER(I) ETHYLSULFATE HEMIHYDRATE
  137. On the molecular structure of gold(I) complexes with heterocyclic thiones. The structure of bis(1,3-thiazolidine-2-thione) gold(I) chloride hydrate
  138. Four-coordinate copper(I) iodide complexes with triphenylphosphine and heterocyclic thione ligands. The crystal structure of [Cu(PPh3)2(pymtH)I]
  139. Study of the geometric preferences of copper(I) halide coordination compounds with triarylphosphines. Crystal structures of [CuCl{P(o-tolyl)3}]2 and [CuBr{P(o-tolyl)3}]2
  140. Study of the geometric preferences of copper(I) halide coordination compounds with triarylphosphines. Crystal structure of [Cu2I2{P(m-tolyl)3}3]
  141. Study of mixed ligand copper(I) complexes with tri-m-tolyl-phosphine (tmtp) and heterocyclic thiones. Crystal structures of bis[μ-S(benzimidazoline-2-thione)(tmtp) copper(I) chloride] and bis[μ-Br(thiazolidine-2-thione)(tmtp) copper(I)]
  142. Copper(I) complexes with tri-o-tolylphosphine and heterocyclic thione ligands. Crystal structures of [(pyrimidine-2-thione)(tri-o-tolylphosphine)copper(I) chloride] and [(pyridine-2-thione)(tri-o-tolylphosphine)copper(I) iodide]
  143. Electrochemical reduction of copper(I) mixed- ligand complexes with phosphines and heterocyclic thiones in acetonitrile solutions with glassy carbon electrodes
  144. Synthesis and photolysis of a new series of Cu(I) complexes with tri-o-tolylphosphine and heterocyclic thiones as ligands. The crystal structure of (thiazolidine-2-thione)(tri-o-tolylphosphine)copper(I)bromide
  145. Synthesis and photolysis of a new series of Cu(I) complexes with tri-m-tolylphosphine and heterocyclic thiones. The crystal structure of bis[μ-iodo(pyridine-2-thione)(tri-m-tolylphosphine)copper(I)]
  146. Synthesis and photolysis of mixed copper(I) complexes with thiones and tri-p-tolylphosphine or triphenylphosphine; X-ray crystal structure of bis[copper(I)(1,3-thiazolidine-2-thione) (tri-p-tolylphosphine)chloride]
  147. Synthesis and photochemical study of Cu(I) complexes with tri-p-tolylphosphine and heterocyclic thiones. The crystal structure of [CuCl(pymtH)(p-CH3C6H4)3P]2
  148. Interaction of Thioamides, Selenoamides and Amides with Di-iodine: A Study of the Mechanism of Action of Anti-thyroid Drugs